Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.

Vanthuyne M, Smith V, De Langhe E, Van Praet J, Arat S, Depresseux G, Westhovens R, Blockmans D, Badot V, Cogan E, De Keyser F, Houssiau FA.

J Rheumatol. 2012 Nov;39(11):2127-33. doi: 10.3899/jrheum.120283. Epub 2012 Sep 15.

PMID:
22984273
2.

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.

Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.

PMID:
22169458
3.

Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.

Srivastava N, Hudson M, Tatibouet S, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Semin Arthritis Rheum. 2015 Oct;45(2):184-9. doi: 10.1016/j.semarthrit.2015.04.009. Epub 2015 Apr 10.

PMID:
25959492
4.

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.

Muangchan C, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research group, Baron M, Pope J.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.

5.

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.

Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M.

Ann Rheum Dis. 2007 Jun;66(6):754-63. Epub 2007 Jan 18.

6.

Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.

Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr.

J Rheumatol. 2007 Jan;34(1):104-9. Epub 2006 Nov 15.

PMID:
17117486
7.

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N; all participating DNSS centers.

Ann Rheum Dis. 2015 Apr;74(4):730-7. doi: 10.1136/annrheumdis-2013-204487. Epub 2014 Jan 3.

8.

Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.

Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr.

Arthritis Rheum. 2007 Aug;56(8):2740-6.

9.

Anti-PM-Scl antibody in patients with systemic sclerosis.

Koschik RW 2nd, Fertig N, Lucas MR, Domsic RT, Medsger TA Jr.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S12-6. Epub 2012 May 29.

PMID:
22261302
10.

Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.

Diab S, Dostrovsky N, Hudson M, Tatibouet S, Fritzler MJ, Baron M, Khalidi N; Canadian Scleroderma Research Group.

J Rheumatol. 2014 Nov;41(11):2179-85. doi: 10.3899/jrheum.140236. Epub 2014 Oct 1.

PMID:
25274885
11.
12.

Diagnosis and classification of systemic sclerosis.

Hachulla E, Launay D.

Clin Rev Allergy Immunol. 2011 Apr;40(2):78-83. doi: 10.1007/s12016-010-8198-y. Review.

PMID:
20143182
13.

Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.

Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, Steen VD, Medsger TA Jr.

J Rheumatol. 2006 May;33(5):1004-13. Epub 2006 Apr 1.

PMID:
16583463
14.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. Epub 2013 Oct 15.

PMID:
24128778
15.

Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis.

Ostojić P, Damjanov N.

Clin Rheumatol. 2006 Jul;25(4):453-7. Epub 2006 Apr 28.

PMID:
16261285
16.

Progression of esophageal dysmotility in systemic sclerosis.

Vischio J, Saeed F, Karimeddini M, Mubashir A, Feinn R, Caldito G, Striegel K, Rothfield N.

J Rheumatol. 2012 May;39(5):986-91. doi: 10.3899/jrheum.110923. Epub 2012 Mar 1.

PMID:
22382346
17.

Renal function is mostly preserved in patients with systemic sclerosis.

Scheja A, Bartosik I, Wuttge DM, Hesselstrand R.

Scand J Rheumatol. 2009;38(4):295-8. doi: 10.1080/03009740802629424.

PMID:
19214870
18.
19.

High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.

Patiwetwitoon S, Wangkaew S, Euathrongchit J, Kasitanon N, Louthrenoo W.

J Clin Rheumatol. 2012 Aug;18(5):229-33. doi: 10.1097/RHU.0b013e318261176f.

PMID:
22832288
20.

A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.

Chang WS, Schollum J, White DH, Solanki KK.

Clin Rheumatol. 2015 Nov;34(11):1921-7. doi: 10.1007/s10067-015-2981-3. Epub 2015 May 29.

PMID:
26022620
Items per page

Supplemental Content

Write to the Help Desk